Does low-dose aspirin reduce preeclampsia and other maternal-fetal complications?

Journal of Family Practice

Volumn 57, Issue 1, 2008, Pages 54-56

  Gauer, Robert ^a   Atlas, Michel ^b   Hill, John ^c  

^a WOMACK ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPYRIDAMOLE; HEPARIN; OZAGREL; ANTITHROMBOCYTIC AGENT;

ANTEPARTUM HEMORRHAGE; CLINICAL TRIAL; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; META ANALYSIS; NEONATAL HEMORRHAGE; NEWBORN DEATH; NOTE; PERINATAL DEATH; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; RISK REDUCTION; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; FEMALE; PRACTICE GUIDELINE; PREGNANCY; REVIEW; RISK FACTOR;

ASPIRIN; FEMALE; HUMANS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 38549153272     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 2001; 322:329-333.
2. Coomarasamy A, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of pre-eclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003; 101:1319-1332.
3. Ruano R, Fontes RS, Zugaib M. Prevention of preeclampsia with low-dose aspirin - a systematic review and meta-analysis of the main randomized controlled trials. Clinics 2005; 60:407-414.
4. Askie LM, Duley L, Henderson-Stewart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369:1791-1798.
5. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complication (review). Cochrane Database Syst Rev 2003; (4):CD004659.
6. Villar J, Abalos E, Nardin JM, et al. Strategies to prevent and treat pre-eclampsia: evidence from randomized controlled trials. Semin Nephrol 2004; 24:607-615.
7. Coomarasamy A, Braunholtz D, Song, F, et al. Individualizing use of aspirin to prevent pre-eclampsia: a framework for clinical decision making. BJOG 2003; 110:882-888.
8. ACOG Committee on Obstetric Practice. Diagnosis and management of pre-eclampsia and eclampsia. ACOG Practice Bulletin, no 33. Int J Gynaecol Obstet 2002; 77:67-75.
9. Brown MA, Brennecke SP, Crowther CA, et al. Aspirin and prevention of pre-eclampsia. Aust NZ J Obstet Gynaecol 1995; 35:38-41.
10. Moutquin JM, Garner PR, Burrows RF, Rey E, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. Can Med Assoc J 1997; 57:907-919.